Literature DB >> 14088839

MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED CANCER.

S KOFMAN, R EISENSTEIN.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTINEOPLASTIC AGENTS; HEMORRHAGE; STREPTOMYCES; THROMBOPENIA; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14088839

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  8 in total

1.  Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.

Authors:  Tristan M Sissung; Phoebe A Huang; Ralph J Hauke; Edel M McCrea; Cody J Peer; Roberto H Barbier; Jonathan D Strope; Ariel M Ley; Mary Zhang; Julie A Hong; David Venzon; Jonathan P Jackson; Kenneth R Brouwer; Patrick Grohar; Jon Glod; Brigitte C Widemann; Theo Heller; David S Schrump; William D Figg
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

3.  Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.

Authors:  Prithiba Mitra; Joseph M Eckenrode; Abhisek Mandal; Amit K Jha; Shaimaa M Salem; Markos Leggas; Jürgen Rohr
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

4.  Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

Authors:  Mary Zhang; Aarti Mathur; Yuwei Zhang; Sichuan Xi; Scott Atay; Julie A Hong; Nicole Datrice; Trevor Upham; Clinton D Kemp; R Taylor Ripley; Gordon Wiegand; Itzak Avital; Patricia Fetsch; Haresh Mani; Daniel Zlott; Robert Robey; Susan E Bates; Xinmin Li; Mahadev Rao; David S Schrump
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

Review 5.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

6.  Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.

Authors:  Christy L Osgood; Nichole Maloney; Christopher G Kidd; Susan Kitchen-Goosen; Laura Segars; Meti Gebregiorgis; Girma M Woldemichael; Min He; Savita Sankar; Stephen L Lessnick; Min Kang; Malcolm Smith; Lisa Turner; Zachary B Madaj; Mary E Winn; Luz-Elena Núñez; Javier González-Sabín; Lee J Helman; Francisco Morís; Patrick J Grohar
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 12.531

7.  Treatment of Paget's disease of bone with mithramycin.

Authors:  J R Condon; S B Reith; J R Nassim; F J Millard; A Hilb; E M Stainthorpe
Journal:  Br Med J       Date:  1971-02-20

8.  Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells.

Authors:  Eun-Sun Choi; Taeho Chung; Jun-Sung Kim; Hakmo Lee; Ki Han Kwon; Nam-Pyo Cho; Sung-Dae Cho
Journal:  J Clin Biochem Nutr       Date:  2013-07-30       Impact factor: 3.114
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.